Tuesday, November 5, 2024
HomeTagsImmune Checkpoint Inhibitors

Immune Checkpoint Inhibitors

Genprex Announces U.S. Patent for REQORSA Immunogene Therapy

Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that the United States Patent...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics